$ENDI
ENDI Corp. Stock $endi

$endi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923014518 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$2.297M	$1.938M	$1.707M
YoY Change	30.35%	13.52%
Cost Of Revenue	$55.02K	$60.75K	$0.00
YoY Change	-50.8%
Gross Profit	$2.242M	$1.877M	$1.707M
YoY Change	1480.22%	9.96%
Gross Profit Margin	97.6%	96.87%	100.0%
Selling, General & Admin			$984.3K
YoY Change
% of Gross Profit			57.66%
Research & Development	$45.13K	$2.844K	$3.871K
YoY Change	-10.97%	-26.53%
% of Gross Profit	2.01%	0.15%	0.23%
Depreciation & Amortization		$20.72K	$0.00
YoY Change
% of Gross Profit		1.1%	0.0%
Operating Expenses	$1.798M	$2.159M	$942.7K
YoY Change	166.56%	129.05%
Operating Profit	$444.5K	-$282.0K	$764.5K
YoY Change	-183.47%	-136.89%
Interest Expense			$0.00
YoY Change
% of Operating Profit			0.0%
Other Income/Expense, Net	$617.2K	$320.2K	-$2.842K
YoY Change	1817.55%	-11368.05%
Pretax Income			-$732.8K
YoY Change
Income Tax	$208.9K	$32.23K	$0.00
% Of Pretax Income
Net Earnings	$852.9K	$5.966K	-$732.8K
YoY Change	-270.46%	-100.81%	-137.04%
Net Earnings / Revenue	37.13%	0.31%	-42.93%
Basic Earnings Per Share	$0.16	$0.00	$0.32
Diluted Earnings Per Share	$0.16	$5.458M	$2.400M
COMMON SHARES
Basic Shares Outstanding	1.800M	1.800M
Diluted Shares Outstanding	5.468M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments			$17.07M
YoY Change
Cash & Equivalents	$9.338M	$9.802M	$642.7K
Short-Term Investments			$2.054M
Other Short-Term Assets		$34.93K	$15.39K
YoY Change		126.96%
Inventory
Prepaid Expenses	$122.4K	$102.4K
Receivables	$916.5K	$772.9K	$39.45K
Other Receivables			$0.00
Total Short-Term Assets	$18.18M	$17.50M	$17.13M
YoY Change	13.04%	2.2%
LONG-TERM ASSETS
Property, Plant & Equipment			$8.650K
YoY Change
Goodwill	$737.9K	$737.9K
YoY Change	247.32%
Intangibles	$3.461M	$1.203M	$0.00
YoY Change
Long-Term Investments			$0.00
YoY Change
Other Assets			$60.05K
YoY Change
Total Long-Term Assets	$7.134M	$4.755M	$331.1K
YoY Change	2073.49%	1336.05%
TOTAL ASSETS
Total Short-Term Assets	$18.18M	$17.50M	$17.13M
Total Long-Term Assets	$7.134M	$4.755M	$331.1K
Total Assets	$25.31M	$22.26M	$17.46M
YoY Change	54.26%	27.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.30K	$12.21K	$16.37K
YoY Change	155.07%	-25.42%
Accrued Expenses	$172.9K	$378.7K	$872.4K
YoY Change	-47.99%	-56.6%
Deferred Revenue	$167.5K	$168.0K
YoY Change	-12.21%
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.164M	$961.5K	$1.087M
YoY Change	305.01%	-11.53%
LONG-TERM LIABILITIES
Long-Term Debt			$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.782M	$828.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.164M	$961.5K	$1.087M
Total Long-Term Liabilities	$1.782M	$828.0K	$0.00
Total Liabilities	$3.946M	$1.790M	$1.087M
YoY Change	638.56%	64.66%
SHAREHOLDERS EQUITY
Retained Earnings	$1.024M	$170.6K
YoY Change	-108.44%
Common Stock	$20.34M	$20.30M
YoY Change	-27.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.36M	$20.47M	$16.37M
YoY Change
Total Liabilities & Shareholders Equity	$25.31M	$22.26M	$17.46M
YoY Change	54.26%	27.49%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$852.9K	$5.966K	-$732.8K
YoY Change	-270.46%	-100.81%	-137.04%
Depreciation, Depletion And Amortization		$20.72K	$0.00
YoY Change
Cash From Operating Activities		$490.4K	$949.3K
YoY Change		-48.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities			$69.60K
YoY Change
Cash From Investing Activities		-$1.503M	$2.849K
YoY Change		-52853.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$123.8K	-$1.582M
YoY Change		-107.83%
NET CHANGE
Cash From Operating Activities		$490.4K	$949.3K
Cash From Investing Activities		-$1.503M	$2.849K
Cash From Financing Activities		$123.8K	-$1.582M
Net Change In Cash		-$888.7K	-$630.3K
YoY Change		41.01%
FREE CASH FLOW
Cash From Operating Activities		$490.4K	$949.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001908984
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ENDI Corp.
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9801659	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10690398	usd
CY2023Q1	us-gaap	Assets Assets	22259921	usd
CY2022Q4	us-gaap	Assets Assets	21471495	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	12209	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	71306	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22259921	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21471495	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	6255614	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	5802395	usd
CY2022Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-56469
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-4284605
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2400 Old Brick Road, Suite 115
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Glen Allen
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	23060
CY2023Q1	dei	City Area Code CityAreaCode	434
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	336-7737
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1800000
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	6408355	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	5860688	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	772859	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	744638	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	102372	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	91473	usd
CY2023Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	384400	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	50000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	34929	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	57446	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	17504574	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	17618466	usd
CY2023Q1	us-gaap	Goodwill Goodwill	737869	usd
CY2022Q4	us-gaap	Goodwill Goodwill	737869	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1203211	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1223926	usd
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1405266	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	450000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1409001	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1441234	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	4755347	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3853029	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	401625	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	23342	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	378665	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	260185	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	168047	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	156859	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	970	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1110	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	961516	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	512802	usd
CY2023Q1	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	828000	usd
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	576000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	828000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	576000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1789516	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1088802	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	20299218	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	20217472	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	170642	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	164676	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	20470405	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20382693	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1937929	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1707124	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	60751	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1877178	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1707124	usd
CY2023Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1149730	usd
CY2022Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	756643	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	81746	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	46769	usd
CY2022Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	28878	usd
CY2023Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	29555	usd
CY2022Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	34358	usd
CY2023Q1	endi	Mutual Fund Expenses MutualFundExpenses	65273	usd
CY2022Q1	endi	Mutual Fund Expenses MutualFundExpenses	47972	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	557993	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	1200	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2844	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3871	usd
CY2023Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	90749	usd
CY2022Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	12078	usd
CY2023Q1	endi	Transaction Expenses TransactionExpenses	0	usd
CY2022Q1	endi	Transaction Expenses TransactionExpenses	0	usd
CY2023Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	134558	usd
CY2022Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	57665	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2159217	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	942665	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-282039	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	764459	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	252000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	-0	usd
CY2023Q1	endi	Fair Value Revaluation Adjustment Of Notes Receivable FairValueRevaluationAdjustmentOfNotesReceivable	334400	usd
CY2022Q1	endi	Fair Value Revaluation Adjustment Of Notes Receivable FairValueRevaluationAdjustmentOfNotesReceivable	0	usd
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	112114	usd
CY2022Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	9799	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	21430	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	104451	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-12641	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-157	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	320238	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2842	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32233	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5966	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	761617	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5457983
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2400000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20382693	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5966	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	81746	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	20470405	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	591909	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	761617	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1353526	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5966	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	761617	usd
CY2023Q1	endi	Fair Value Revaluation Adjustment Of Notes Receivable FairValueRevaluationAdjustmentOfNotesReceivable	334400	usd
CY2022Q1	endi	Fair Value Revaluation Adjustment Of Notes Receivable FairValueRevaluationAdjustmentOfNotesReceivable	-0	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	252000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	81746	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20715	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28221	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	138606	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	10899	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-22517	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4567	usd
CY2023Q1	endi	Increase Decrease In Deferred Tax Assets Net IncreaseDecreaseInDeferredTaxAssetsNet	-32233	usd
CY2022Q1	endi	Increase Decrease In Deferred Tax Assets Net IncreaseDecreaseInDeferredTaxAssetsNet	-0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-59097	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	378283	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	118480	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	321717	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	11188	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-140	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	490371	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	949295	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	547667	usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	-2849	usd
CY2023Q1	endi	Payments To Acquire Private Company PaymentsToAcquirePrivateCompany	955266	usd
CY2022Q1	endi	Payments To Acquire Private Company PaymentsToAcquirePrivateCompany	-0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1502933	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2849	usd
CY2023Q1	endi	Proceeds From Payments To Contributions From Affiliates ProceedsFromPaymentsToContributionsFromAffiliates	123823	usd
CY2022Q1	endi	Proceeds From Payments To Contributions From Affiliates ProceedsFromPaymentsToContributionsFromAffiliates	0	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-1582396	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	123823	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1582396	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-888739	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-630252	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10690398	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1272924	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9801659	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	642672	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2023Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	384400	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><b>Use of Estimates</b></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">In accordance with GAAP the preparation of these condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">On an ongoing basis, management evaluates its estimates and judgments, including, among other items, those related to fair value of investments, revenue recognition, accrued expenses, financing operations, fair value of goodwill, fixed asset lives and impairment, lease right-of-use assets and impairment, deferred tax assets, liabilities and valuation allowance, other assets, the present value of lease liabilities, and contingencies and litigation. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are <em style="font: inherit;">not</em> readily apparent from other sources. Actual results <em style="font: inherit;"> may </em>differ from these estimates under different assumptions and conditions. These accounting policies are described at relevant sections in the notes to the unaudited condensed consolidated financial statements.</p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"/>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><b>Concentration of Credit Risk</b></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash, cash equivalents, accounts receivable, and notes receivable. The Company places its cash with high-quality financial institutions and, at times, exceeds the FDIC and CDIC insurance limit. The Company extends credit based on an evaluation of customers’ financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer’s financial condition. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses.</p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"/>
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3239	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2283	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1244	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	endi	Number Of Domain Names Owned NumberOfDomainNamesOwned	242	pure
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20715	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	576000	usd
CY2023Q1	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	828000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	252000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	198277
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	81746	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1409001	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32233	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	15750
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2050000
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2022Q3	endi	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Accounts Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivables	35027	usd
CY2022Q3	endi	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Note Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNoteReceivables	50000	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	51933	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	119785	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	3431	usd
CY2022Q3	us-gaap	Goodwill Goodwill	737869	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	1255000	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets	1249556	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	20506	usd
CY2022Q3	endi	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses	513922	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue	203547	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	648	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	18637576	usd
CY2022Q3	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	300000	usd
CY2022Q4	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	50000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1249556	usd
CY2022Q4	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	939556	usd
CY2022Q3	us-gaap	Goodwill Fair Value Disclosure GoodwillFairValueDisclosure	1677425	usd
CY2022Q4	us-gaap	Goodwill Fair Value Disclosure GoodwillFairValueDisclosure	737869	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	252000	usd
CY2023Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1255000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1255000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	51789	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	31074	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1203211	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1223926	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20715	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	pure
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	23914	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	19795	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	17800000
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0

Files In Submission

Name	View Source	Status
0001437749-23-014518-index-headers.html	Edgar Link	pending
0001437749-23-014518-index.html	Edgar Link	pending
0001437749-23-014518.txt	Edgar Link	pending
0001437749-23-014518-xbrl.zip	Edgar Link	pending
endi-20230331.xsd	Edgar Link	pending
endi20230331_10q.htm	Edgar Link	pending
ex_498047.htm	Edgar Link	pending
ex_498048.htm	Edgar Link	pending
ex_498049.htm	Edgar Link	pending
ex_498050.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
endi-20230331_lab.xml	Edgar Link	unprocessable
endi-20230331_def.xml	Edgar Link	unprocessable
endi20230331_10q_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
endi-20230331_cal.xml	Edgar Link	unprocessable
endi-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ENDI
ENDI Corp. Stock $endi

2023 Q2 Form 10-Q Financial Statement

#000143774923014518 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENDI ENDI Corp. Stock $endi

2023 Q2 Form 10-Q Financial Statement

#000143774923014518 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENDI
ENDI Corp. Stock $endi